A dietary supplement trade association, the Council for Responsible Nutrition, has responded to the Physicians' Health Study II, which examines the effects of vitamin E and C supplementation on cardiovascular events in male physicians and was presented at the American Heart Association's Scientific Sessions held in New Orleans.
CRN representative, Andrew Shao, said: "although the [study's] results did not demonstrate an overall benefit, the results also do not discount the earlier epidemiological data showing that people with high intakes of vitamins E and C may have a lower risk of cardiovascular disease. This study raises an interesting set of scientific challenges as to why the benefits found in observational studies have not been confirmed in this kind of trial."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
CRN comments on Physician's Health trial
A dietary supplement trade association, the Council for Responsible Nutrition, has responded to the Physicians' Health Study II, which examines the effects of vitamin E and C supplementation on cardiovascular events in male physicians and was presented at the American Heart Association's Scientific Sessions held in New Orleans.
CRN representative, Andrew Shao, said: "although the [study's] results did not demonstrate an overall benefit, the results also do not discount the earlier epidemiological data showing that people with high intakes of vitamins E and C may have a lower risk of cardiovascular disease. This study raises an interesting set of scientific challenges as to why the benefits found in observational studies have not been confirmed in this kind of trial."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
Become a subscriber
£820
Or £77 per month
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze